Qidi Ying - Concepedia

Author

Qidi Ying

Also Known As

Q. Ying, Qianliang Ying, Qidi Ying

Publications

415

Citations

H-Index

Concepts

All Affiliations

Qidi Ying is an author at The University of Western Australia specializing in immunology, inflammation, and atherosclerosis.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	80
2	Immunology	2	2	80
3	Pharmacology	2	2	80
4	Biochemistry	1	1	67
5	Chronic Inflammation	1	1	13

Qidi Ying

Publications

213

Citations

H-Index

Page 1

	Year	Citations
Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment Qian Yu, Minda Zhang, Qidi Ying, Cell Death and Disease	2019	97
PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein(a) particles in statin-treated patients with elevated lipoprotein(a) Gerald F. Watts, Dick C. Chan, Jing Pang, Metabolism InflammationMetabolic SyndromeBiochemistryCardiovascular DiseaseMedicine	2020	67
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin‐treated patients with very high apolipoprotein(a) concentration Qidi Ying, Dick C. Chan, Jing Pang, Journal of Internal Medicine	2022	14
G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE −/− mice Lifen Qian, Lingman Ma, Guanzhong Wu, Vascular Pharmacology InflammationAnti-inflammatoryAnti-atherosclerosis EffectsMedicineImmunology	2017	13
Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid? Natalie C. Ward, Qidi Ying, Dick C. Chan, Journal of clinical lipidology	2023	12
Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments? Qidi Ying, Annalisa Ronca, Dick C. Chan, European Journal of Clinical Investigation	2022	10

Page 1